logo

0.1901

0.19 (-1.80%)

As of Jun 14, 2022

Salarius Pharmaceuticals, Inc. [SLRX]

Source: 

Company Overview

Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical need. Specifically, we are developing treatments for cancers caused by dysregulated gene expression, i.e., genes which are incorrectly turned on or off.

CountryUnited States
Headquartershoustontexas
Phone Number346-772-0346
Industry
manufacturing
CEODavid J. Arthur
Websitewww.salariuspharma.com